These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22531300)

  • 1. Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma.
    Michel D; Chitanda JM; Balogh R; Yang P; Singh J; Das U; El-Aneed A; Dimmock J; Verrall R; Badea I
    Eur J Pharm Biopharm; 2012 Aug; 81(3):548-56. PubMed ID: 22531300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.
    Michel D; Mohammed-Saeid W; Getson H; Roy C; Poorghorban M; Chitanda JM; Verrall R; Badea I
    Int J Nanomedicine; 2016; 11():6703-6712. PubMed ID: 28003746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
    Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
    Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
    Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
    Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
    Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
    Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent.
    Dev S; Prabhakaran P; Filgueira L; Iyer KS; Raston CL
    Nanoscale; 2012 Apr; 4(8):2575-9. PubMed ID: 22193941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.
    Shao J; Zheng D; Jiang Z; Xu H; Hu Y; Li X; Lu X
    Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):267-74. PubMed ID: 21349881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment.
    Sun Y; Du L; Liu Y; Li X; Li M; Jin Y; Qian X
    Int J Pharm; 2014 Jul; 469(1):31-9. PubMed ID: 24746691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Macromol Biosci; 2010 Oct; 10(10):1141-51. PubMed ID: 20572274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.
    Gil ES; Li J; Xiao H; Lowe TL
    Biomacromolecules; 2009 Mar; 10(3):505-16. PubMed ID: 19216528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
    Memisoglu-Bilensoy E; Doğan AL; Hincal AA
    J Pharm Pharmacol; 2006 May; 58(5):585-9. PubMed ID: 16640826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route.
    Mangalathillam S; Rejinold NS; Nair A; Lakshmanan VK; Nair SV; Jayakumar R
    Nanoscale; 2012 Jan; 4(1):239-50. PubMed ID: 22080352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery:
    Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P
    J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.